Literature DB >> 11472971

Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid.

R Bals1, D J Weiner, R L Meegalla, F Accurso, J M Wilson.   

Abstract

The link between the genetic defect in cystic fibrosis (CF) and the recently described breach in pulmonary host defense has focused on the role of salt and water metabolism in the airways. Using a human bronchial xenograft model we demonstrate a salt-independent abnormality in bacterial killing in CF airway surface fluid (ASF). Biochemical characterization implicates the absence or dysfunction of a molecule critical to the constitution of normal bacterial killing. Our study suggests that CF transmembrane conductance regulator (CFTR) deficiency causes a primary abnormality in the composition of ASF that leads to a salt-independent defect in host defense. Importantly, this defect is corrected by adenovirus-mediated gene transfer of CFTR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472971     DOI: 10.1165/ajrcmb.25.1.4436

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  21 in total

Review 1.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Roles of antimicrobial peptides such as defensins in innate and adaptive immunity.

Authors:  J J Oppenheim; A Biragyn; L W Kwak; D Yang
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

Authors:  R B Moss
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 4.  Host defense peptides in the oral cavity and the lung: similarities and differences.

Authors:  G Diamond; N Beckloff; L K Ryan
Journal:  J Dent Res       Date:  2008-10       Impact factor: 6.116

5.  Abnormalities in the pulmonary innate immune system in cystic fibrosis.

Authors:  Theo J Moraes; Jonathan Plumb; Raiza Martin; Eric Vachon; Vera Cherepanov; Adeline Koh; Carola Loeve; Jenny Jongstra-Bilen; Joanna H Zurawska; Julianne V Kus; Lori L Burrows; Sergio Grinstein; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-17       Impact factor: 6.914

6.  Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.

Authors:  Nicholas W Keiser; Susan E Birket; Idil A Evans; Scott R Tyler; Adrianne K Crooke; Xingshen Sun; Weihong Zhou; Joseph R Nellis; Elizabeth K Stroebele; Kengyeh K Chu; Guillermo J Tearney; Mark J Stevens; J Kirk Harris; Steven M Rowe; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2015-06       Impact factor: 6.914

7.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

8.  Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs.

Authors:  David K Meyerholz; Branka Grubor; Jack M Gallup; Howard D Lehmkuhl; Richard D Anderson; Tatjana Lazic; Mark R Ackermann
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs.

Authors:  Stefanos Voglis; Kieran Quinn; Elizabeth Tullis; Mingyao Liu; Melanie Henriques; Celia Zubrinich; Oscar Peñuelas; Holman Chan; Frances Silverman; Vera Cherepanov; Neil Orzech; Aye Aye Khine; André Cantin; Arthur S Slutsky; Gregory P Downey; Haibo Zhang
Journal:  Am J Respir Crit Care Med       Date:  2009-04-30       Impact factor: 21.405

10.  Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.

Authors:  David J Serisier; Mary P Carroll; Janis K Shute; Simon A Young
Journal:  Respir Res       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.